Profile
APDN DHR-PB TMO DHR IQV A
Company Name Applied DNA Sciences, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $9.40M $916.76B $209.20B $175.69B $39.38B $38.46B
Employees 0.05K 79.00K 122.00K 61.00K 88.00K 17.40K
CEO Dr. James A. Hayward Ph.D., Sc.D. Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
APDN DHR-PB TMO DHR IQV A
Quant Rating Score 5 5 3 3 3 3
Quant Rating Strong Buy Strong Buy Neutral Neutral Neutral Neutral
Trading
APDN DHR-PB TMO DHR IQV A
Last Close $0.1863 $1261.26 $546.92 $243.25 $216.99 $133.86
High 52 $5 $1261.26 $624.21 $280.76 $259.1 $154.64
Low 52 $0.18 $1261.26 $528.82 $224.58 $205.82 $125.42
Price vs. 52 Week High -96.27 % 0 % -12.38 % -13.36 % -16.25 % -13.44 %
Price vs. 52 Week Low 3.5 % 0 % 3.42 % 8.31 % 5.43 % 6.73 %
Total Return
APDN DHR-PB TMO DHR IQV A
1 Month Return -40.86 % 0 % -8.38 % -10.02 % -5.35 % -6.93 %
3 Month Return -48.25 % 0 % -8.71 % -8.96 % -6.25 % -1.28 %
6 Month Return -94.6 % 0 % -7.78 % -4 % -7.3 % -10.62 %
9 Month Return -67.08 % 0 % 0.01 % -1.45 % -0.41 % 1.17 %
YTD Return -69.8 % 0 % 3.04 % 5.15 % -6.22 % -3.72 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APDN DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.43 % 0.28 % 0.43 % - 0.71 %
Dividend Paid and Capex Coverage Ration (TTM) -83.09 % 3.16 % 9.33 % 3.07 % 4.18 % 2.79 %
Dividend Per Share (TTM) - 1.05 % 1.52 % 1.05 % - 0.94 %
Payout Ratio (TTM) -1.06 % 17.87 % 9.29 % 19.86 % - 19.25 %
Growth
APDN DHR-PB TMO DHR IQV A
Asset Growth -38.69 % 0.16 % 1.62 % 0.16 % 5.3 % 2.19 %
Gross Profit Growth 9.49 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth -26.43 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year 107.44 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year -80.69 % 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year -85.28 % 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth 21.59 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth -18.73 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share 76.64 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share 95.2 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share 98.74 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth 21.59 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) 30.74 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 83.28 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG 94.93 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG 98.23 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth 18.58 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth 18.58 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -74.11 % 5.13 % 7.75 % 5.13 % 8.21 % 12.05 %
Share Holder 3 Year Equity Growth Per Share -74.05 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -62.99 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share -97.59 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth -100 % -1.19 % 16.73 % -1.19 % - 7.8 %
Dividend 3 Year Growth Per Share - 28 % 59.21 % 28 % - 25.46 %
Dividend 5 Year Growth Per Share - 80.2 % 104.77 % 80.2 % - 51.49 %
Dividend 10 Year Growth Per Share - 1389.16 % 125.8 % 1389.16 % - 97.03 %
Debt Growth - -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth 33.49 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 30 Sep 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
APDN DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 15.61 % 58.45 % 41.24 % 59.61 % 29.83 % 54.86 %
Return on Assets TTM -44.13 % 5.33 % 6.11 % 4.83 % 5.17 % 12.85 %
Return on Equity TTM -136.86 % 8.42 % 13.01 % 7.48 % 21.5 % 23.4 %
Return on Capital Employed TTM -109.22 % 7.39 % 8.36 % 5.43 % 10.8 % 17.47 %
Net Income Per EBT TTM 99.67 % 83.98 % 89.76 % 102.75 % 93.79 % 91.75 %
EBT Per Ebit TTM 49.52 % 94.74 % 95.34 % 95.2 % 68.68 % 102.39 %
EBIT Per Revenue TTM -439.2 % 21.3 % 16.92 % 19.87 % 14.2 % 23.15 %
Cash Flow To Debt Ratio TTM -1513.93 % 36.11 % 25.77 % 35.88 % 19.08 % 60.91 %
Receivables Turnover TTM 6.61 7.76 5.13 5.71 4.73 5.3
Payables Turnover TTM 1.79 6.49 9.55 5.07 3.14 5.9
Inventory Turnover TTM 6.1 4.12 4.58 3.02 55.27 3
Fixed Asset Turnover TTM 242.92 % 463.28 % 450.17 % 413.59 % 1989.51 % 449.31 %
Asset Turnover TTM 20.36 % 31.45 % 42.22 % 24.85 % 56.51 % 59.09 %
Operating Cash Flow Per Share TTM -3.27 9.27 23.82 8.7 14.16 6.16
Free Cash Flow Per Share TTM -3.25 7.39 22.76 6.93 10.77 4.89
Cash Per Share TTM 260.13 % 937.04 % 1739.53 % 363.35 % 940.14 % 613.45 %
Operating Cash Flow Sales Ratio TTM -386.75 % 26.52 % 21.48 % 31.39 % 16.78 % 27.49 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.39 % 79.76 % 95.55 % 79.68 % 76.07 % 79.34 %
Cash Flow Coverage Ratios TTM -1513.93 % 36.11 % 25.77 % 35.88 % 19.08 % 60.91 %
Price To Free Cash Flows Ratio TTM -0.72 31.67 24.06 35.07 20.08 27.14
Price To Operating Cash Flows Ratio TTM -0.06 26.24 22.96 27.97 15.33 21.74
Price Cash Flow Ratio TTM -0.06 26.24 22.96 27.97 15.33 21.74
Income Statement (TTM)
APDN DHR-PB TMO DHR IQV A
Revenue $0.01B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $0.01B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 41.39% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.01B $7.55B $10.8B $7.55B $3.21B $1.68B
Net Income $-0.01B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -15.21 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
APDN DHR-PB TMO DHR IQV A
Long Term Debt $0B $17.66B $31.31B $17.66B $12.96B $2.85B
Total Liabilities $0.01B $31B $51.88B $31B $20.57B $4.92B
Total Equity $0B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.01B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
APDN DHR-PB TMO DHR IQV A
Net Income $-0.01B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-0.82B $-0.52B $-0.82B $0B $-0.27B
Operating Cash Flow $-0.01B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 133.7
ACRS Aclaris Therapeutics, Inc. 2.5416
AKU Akumin Inc. 0.2887
AWH Aspira Women's Health Inc. 0.8201
BDSX Biodesix, Inc. 1.395
BIAF bioAffinity Technologies, Inc. 1.28
BIAFW bioAffinity Technologies, Inc. 0.9495
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.2648
BNR Burning Rock Biotech Limited 3.64
CDNA CareDx, Inc 23.21
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.8618
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 216.07
CSTL Castle Biosciences, Inc. 32.77
DGX Quest Diagnostics Incorporated 161.78
DHR Danaher Corporation 239.42
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to APDN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 296.27
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 131.51
VXF Vanguard Extended Market Index Fund 0 199.065
VTSAX Vanguard Total Stock Market Index Fund 0 144.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 152.68
VITSX Vanguard Total Stock Market Index Fund 0 144.82
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 152.69
VEMPX Vanguard Extended Market Index InstlPlus 0 376.8
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 271.65
Unlock